Global Contraceptive Drugs and Devices Market by Product (Vaginal Rings, Condoms, Vaginal Contraceptive Drugs, Oral, Diaphragms, Intra-uterine Devices, Male Contraceptive Devices, Sub-Dermal Implants, Female Contraceptive Devices, Topical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Industry Insights
Contraception is also known as fertility or birth control. These are methods that prevent pregnancy. These drugs and devices alter the process of ovulation and act as physical barriers between the sperm ovum. Proper use of contraceptives such as male and female condoms can help prevent the spread of sexually transmitted disease. For prevention of pregnancy, there are several options for behavioral, dual protection, and emergency contraceptives. Global contraceptives market includes oral, vaginal and injectable contraceptives drugs as well as male/female contraceptive device. These products can be purchased at a variety of outlets, including pharmacies and chemists as well as reproductive health and fertility centres. The market is driven by a rising number of government initiatives to raise awareness about these devices and drugs. The market is also driven by the rising prevalence of sexually transmitted disease. Social and political factors also influence the market for contraceptives.
Product Insights
This study focuses on key product segments such as contraceptive drugs, contraceptive pills, and contraceptive products. Contraceptives drugs are in high demand. The easiest way to contraceptive is now possible with the help of technology. These pills prevent implantation in the uterus when taken within 2 to 3 days of unprotected sexual contact. Their simplicity makes them an attractive contraceptive on the market. Strong demand is also seen for injectable and topical contraceptives. Future growth in contraceptive devices and drugs will be fueled by the introduction of inexpensive contraceptives like Sino-Implant (II), and the existence of a large contraceptives product portfolio (e.g. Male contraceptive drugs for men, Pill-Plus and the AG200-15 Contraceptive patch.
Regional Insights
This study focuses on North America, Europe and Asia Pacific. RoW is also included. Europe and North America were the dominant markets in 2013, owing to their advanced healthcare infrastructure, high contraceptive drug adoption rates, and increasing government initiatives to increase user awareness. However, the presence of high contraception-related unmet medical needs coupled with rising consumer awareness levels and disposable incomes will help the Asia-Pacific contraceptive drugs and devices market to register the highest growth rate during the forecast period. These countries have implemented healthcare policies that aim to increase the availability of contraceptive devices and drugs, which would reduce population growth.
Competitive Insights
Bayer Healthcare AG and Merck & Co. are key players in this market.
Up Market Research published a new report titled “Contraceptive Drugs and Devices Market research report which is segmented by Product (Vaginal Rings, Condoms, Vaginal Contraceptive Drugs, Oral, Diaphragms, Intra-uterine Devices, Male Contraceptive Devices, Sub-Dermal Implants, Female Contraceptive Devices, Topical), By Players/Companies Bayer Healthcare AG, Merck & Co, BioSante Pharmaceuticals, Agile Therapeutics Inc, Mayer Laboratories Inc, Church & Dwight Co Inc, Teva Pharmaceutical Industries Ltd , Pantarhei Bioscience BV, Pfizer Inc, Warmer Chilcott Company inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Contraceptive Drugs and Devices Market Research Report |
| By Product | Vaginal Rings, Condoms, Vaginal Contraceptive Drugs, Oral, Diaphragms, Intra-uterine Devices, Male Contraceptive Devices, Sub-Dermal Implants, Female Contraceptive Devices, Topical |
| By Companies | Bayer Healthcare AG, Merck & Co, BioSante Pharmaceuticals, Agile Therapeutics Inc, Mayer Laboratories Inc, Church & Dwight Co Inc, Teva Pharmaceutical Industries Ltd , Pantarhei Bioscience BV, Pfizer Inc, Warmer Chilcott Company inc |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 249 |
| Number of Tables & Figures | 175 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Contraceptive Drugs and Devices Market Report Segments:
The market is segmented by Product (Vaginal Rings, Condoms, Vaginal Contraceptive Drugs, Oral, Diaphragms, Intra-uterine Devices, Male Contraceptive Devices, Sub-Dermal Implants, Female Contraceptive Devices, Topical).
Contraceptive Drugs and Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Contraceptive Drugs and Devices Market
Overview of the regional outlook of the Contraceptive Drugs and Devices Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Contraceptive Drugs and Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Contraceptive Drugs and Devices Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Vaginal Rings
2. Condoms
3. Vaginal Contraceptive Drugs
4. Oral
5. Diaphragms
6. Intra-uterine Devices
7. Male Contraceptive Devices
8. Sub-Dermal Implants
9. Female Contraceptive Devices
10. Topical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contraceptive Drugs and Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Contraceptive Drugs and Devices Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contraceptive Drugs and Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contraceptive Drugs and Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contraceptive Drugs and Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contraceptive Drugs and Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contraceptive Drugs and Devices Market Size & Forecast, 2018-2028
4.5.1 Contraceptive Drugs and Devices Market Size and Y-o-Y Growth
4.5.2 Contraceptive Drugs and Devices Market Absolute $ Opportunity
Chapter 5 Global Contraceptive Drugs and Devices Market Analysis and Forecast by Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product
5.1.2 Basis Point Share (BPS) Analysis by Product
5.1.3 Absolute $ Opportunity Assessment by Product
5.2 Contraceptive Drugs and Devices Market Size Forecast by Product
5.2.1 Vaginal Rings
5.2.2 Condoms
5.2.3 Vaginal Contraceptive Drugs
5.2.4 Oral
5.2.5 Diaphragms
5.2.6 Intra-uterine Devices
5.2.7 Male Contraceptive Devices
5.2.8 Sub-Dermal Implants
5.2.9 Female Contraceptive Devices
5.2.10 Topical
5.3 Market Attractiveness Analysis by Product
Chapter 6 Global Contraceptive Drugs and Devices Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Contraceptive Drugs and Devices Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Contraceptive Drugs and Devices Analysis and Forecast
8.1 Introduction
8.2 North America Contraceptive Drugs and Devices Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Contraceptive Drugs and Devices Market Size Forecast by Product
8.6.1 Vaginal Rings
8.6.2 Condoms
8.6.3 Vaginal Contraceptive Drugs
8.6.4 Oral
8.6.5 Diaphragms
8.6.6 Intra-uterine Devices
8.6.7 Male Contraceptive Devices
8.6.8 Sub-Dermal Implants
8.6.9 Female Contraceptive Devices
8.6.10 Topical
8.7 Basis Point Share (BPS) Analysis by Product
8.8 Absolute $ Opportunity Assessment by Product
8.9 Market Attractiveness Analysis by Product
Chapter 9 Europe Contraceptive Drugs and Devices Analysis and Forecast
9.1 Introduction
9.2 Europe Contraceptive Drugs and Devices Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Contraceptive Drugs and Devices Market Size Forecast by Product
9.6.1 Vaginal Rings
9.6.2 Condoms
9.6.3 Vaginal Contraceptive Drugs
9.6.4 Oral
9.6.5 Diaphragms
9.6.6 Intra-uterine Devices
9.6.7 Male Contraceptive Devices
9.6.8 Sub-Dermal Implants
9.6.9 Female Contraceptive Devices
9.6.10 Topical
9.7 Basis Point Share (BPS) Analysis by Product
9.8 Absolute $ Opportunity Assessment by Product
9.9 Market Attractiveness Analysis by Product
Chapter 10 Asia Pacific Contraceptive Drugs and Devices Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Contraceptive Drugs and Devices Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Contraceptive Drugs and Devices Market Size Forecast by Product
10.6.1 Vaginal Rings
10.6.2 Condoms
10.6.3 Vaginal Contraceptive Drugs
10.6.4 Oral
10.6.5 Diaphragms
10.6.6 Intra-uterine Devices
10.6.7 Male Contraceptive Devices
10.6.8 Sub-Dermal Implants
10.6.9 Female Contraceptive Devices
10.6.10 Topical
10.7 Basis Point Share (BPS) Analysis by Product
10.8 Absolute $ Opportunity Assessment by Product
10.9 Market Attractiveness Analysis by Product
Chapter 11 Latin America Contraceptive Drugs and Devices Analysis and Forecast
11.1 Introduction
11.2 Latin America Contraceptive Drugs and Devices Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Contraceptive Drugs and Devices Market Size Forecast by Product
11.6.1 Vaginal Rings
11.6.2 Condoms
11.6.3 Vaginal Contraceptive Drugs
11.6.4 Oral
11.6.5 Diaphragms
11.6.6 Intra-uterine Devices
11.6.7 Male Contraceptive Devices
11.6.8 Sub-Dermal Implants
11.6.9 Female Contraceptive Devices
11.6.10 Topical
11.7 Basis Point Share (BPS) Analysis by Product
11.8 Absolute $ Opportunity Assessment by Product
11.9 Market Attractiveness Analysis by Product
Chapter 12 Middle East & Africa (MEA) Contraceptive Drugs and Devices Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Contraceptive Drugs and Devices Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Contraceptive Drugs and Devices Market Size Forecast by Product
12.6.1 Vaginal Rings
12.6.2 Condoms
12.6.3 Vaginal Contraceptive Drugs
12.6.4 Oral
12.6.5 Diaphragms
12.6.6 Intra-uterine Devices
12.6.7 Male Contraceptive Devices
12.6.8 Sub-Dermal Implants
12.6.9 Female Contraceptive Devices
12.6.10 Topical
12.7 Basis Point Share (BPS) Analysis by Product
12.8 Absolute $ Opportunity Assessment by Product
12.9 Market Attractiveness Analysis by Product
Chapter 13 Competition Landscape
13.1 Contraceptive Drugs and Devices Market: Competitive Dashboard
13.2 Global Contraceptive Drugs and Devices Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Bayer Healthcare AG
13.3.2 Merck & Co
13.3.3 BioSante Pharmaceuticals
13.3.4 Agile Therapeutics Inc
13.3.5 Mayer Laboratories Inc
13.3.6 Church & Dwight Co Inc
13.3.7 Teva Pharmaceutical Industries LtdÂ
13.3.8 Pantarhei Bioscience BV
13.3.9 Pfizer Inc
13.3.10 Warmer Chilcott Company inc
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contraceptive Drugs and Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contraceptive Drugs and Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contraceptive Drugs and Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contraceptive Drugs and Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contraceptive Drugs and Devices Market Size & Forecast, 2018-2028
4.5.1 Contraceptive Drugs and Devices Market Size and Y-o-Y Growth
4.5.2 Contraceptive Drugs and Devices Market Absolute $ Opportunity
Chapter 5 Global Contraceptive Drugs and Devices Market Analysis and Forecast by Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product
5.1.2 Basis Point Share (BPS) Analysis by Product
5.1.3 Absolute $ Opportunity Assessment by Product
5.2 Contraceptive Drugs and Devices Market Size Forecast by Product
5.2.1 Vaginal Rings
5.2.2 Condoms
5.2.3 Vaginal Contraceptive Drugs
5.2.4 Oral
5.2.5 Diaphragms
5.2.6 Intra-uterine Devices
5.2.7 Male Contraceptive Devices
5.2.8 Sub-Dermal Implants
5.2.9 Female Contraceptive Devices
5.2.10 Topical
5.3 Market Attractiveness Analysis by Product
Chapter 6 Global Contraceptive Drugs and Devices Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Contraceptive Drugs and Devices Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Contraceptive Drugs and Devices Analysis and Forecast
8.1 Introduction
8.2 North America Contraceptive Drugs and Devices Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Contraceptive Drugs and Devices Market Size Forecast by Product
8.6.1 Vaginal Rings
8.6.2 Condoms
8.6.3 Vaginal Contraceptive Drugs
8.6.4 Oral
8.6.5 Diaphragms
8.6.6 Intra-uterine Devices
8.6.7 Male Contraceptive Devices
8.6.8 Sub-Dermal Implants
8.6.9 Female Contraceptive Devices
8.6.10 Topical
8.7 Basis Point Share (BPS) Analysis by Product
8.8 Absolute $ Opportunity Assessment by Product
8.9 Market Attractiveness Analysis by Product
Chapter 9 Europe Contraceptive Drugs and Devices Analysis and Forecast
9.1 Introduction
9.2 Europe Contraceptive Drugs and Devices Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Contraceptive Drugs and Devices Market Size Forecast by Product
9.6.1 Vaginal Rings
9.6.2 Condoms
9.6.3 Vaginal Contraceptive Drugs
9.6.4 Oral
9.6.5 Diaphragms
9.6.6 Intra-uterine Devices
9.6.7 Male Contraceptive Devices
9.6.8 Sub-Dermal Implants
9.6.9 Female Contraceptive Devices
9.6.10 Topical
9.7 Basis Point Share (BPS) Analysis by Product
9.8 Absolute $ Opportunity Assessment by Product
9.9 Market Attractiveness Analysis by Product
Chapter 10 Asia Pacific Contraceptive Drugs and Devices Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Contraceptive Drugs and Devices Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Contraceptive Drugs and Devices Market Size Forecast by Product
10.6.1 Vaginal Rings
10.6.2 Condoms
10.6.3 Vaginal Contraceptive Drugs
10.6.4 Oral
10.6.5 Diaphragms
10.6.6 Intra-uterine Devices
10.6.7 Male Contraceptive Devices
10.6.8 Sub-Dermal Implants
10.6.9 Female Contraceptive Devices
10.6.10 Topical
10.7 Basis Point Share (BPS) Analysis by Product
10.8 Absolute $ Opportunity Assessment by Product
10.9 Market Attractiveness Analysis by Product
Chapter 11 Latin America Contraceptive Drugs and Devices Analysis and Forecast
11.1 Introduction
11.2 Latin America Contraceptive Drugs and Devices Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Contraceptive Drugs and Devices Market Size Forecast by Product
11.6.1 Vaginal Rings
11.6.2 Condoms
11.6.3 Vaginal Contraceptive Drugs
11.6.4 Oral
11.6.5 Diaphragms
11.6.6 Intra-uterine Devices
11.6.7 Male Contraceptive Devices
11.6.8 Sub-Dermal Implants
11.6.9 Female Contraceptive Devices
11.6.10 Topical
11.7 Basis Point Share (BPS) Analysis by Product
11.8 Absolute $ Opportunity Assessment by Product
11.9 Market Attractiveness Analysis by Product
Chapter 12 Middle East & Africa (MEA) Contraceptive Drugs and Devices Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Contraceptive Drugs and Devices Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Contraceptive Drugs and Devices Market Size Forecast by Product
12.6.1 Vaginal Rings
12.6.2 Condoms
12.6.3 Vaginal Contraceptive Drugs
12.6.4 Oral
12.6.5 Diaphragms
12.6.6 Intra-uterine Devices
12.6.7 Male Contraceptive Devices
12.6.8 Sub-Dermal Implants
12.6.9 Female Contraceptive Devices
12.6.10 Topical
12.7 Basis Point Share (BPS) Analysis by Product
12.8 Absolute $ Opportunity Assessment by Product
12.9 Market Attractiveness Analysis by Product
Chapter 13 Competition Landscape
13.1 Contraceptive Drugs and Devices Market: Competitive Dashboard
13.2 Global Contraceptive Drugs and Devices Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Bayer Healthcare AG
13.3.2 Merck & Co
13.3.3 BioSante Pharmaceuticals
13.3.4 Agile Therapeutics Inc
13.3.5 Mayer Laboratories Inc
13.3.6 Church & Dwight Co Inc
13.3.7 Teva Pharmaceutical Industries LtdÂ
13.3.8 Pantarhei Bioscience BV
13.3.9 Pfizer Inc
13.3.10 Warmer Chilcott Company inc
Segments Covered in the Report
The global Contraceptive Drugs and Devices market has been segmented based on
By Product
The global Contraceptive Drugs and Devices market has been segmented based on
By Product
- Vaginal Rings
- Condoms
- Vaginal Contraceptive Drugs
- Oral
- Diaphragms
- Intra-uterine Devices
- Male Contraceptive Devices
- Sub-Dermal Implants
- Female Contraceptive Devices
- Topical
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Bayer Healthcare AG
- Merck & Co
- BioSante Pharmaceuticals
- Agile Therapeutics Inc
- Mayer Laboratories Inc
- Church & Dwight Co Inc
- Teva Pharmaceutical Industries LtdÂ
- Pantarhei Bioscience BV
- Pfizer Inc
- Warmer Chilcott Company inc
Our Clients
Related Reports
Some other reports from this category!
